Schizoaffective Disorder

• FDA label_change · 2025-12-18
  FDA Approved: VRAYLAR — Supplemental Application (Allergan, Inc.)

  FDA approved a supplemental application for VRAYLAR (cariprazine) from Allergan, Inc.

• FDA label_change · 2025-01-22
  FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)

  The FDA approved a supplemental application for CLOZARIL (clozapine) submitted by HLS Therapeutics USA, Inc., resulting in an update to the …

• FDA label_change · 2021-11-10
  FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)

  The FDA approved a supplemental application for VERSACLOZ (clozapine) submitted by TruPharma LLC.

• FDA label_change · 2014-09-30
  FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)

  FDA approved a supplemental labeling application for CLOZARIL (clozapine) submitted by HLS Therapeutics (USA), Inc.

• FDA label_change · 2007-04-27
  FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for INVEGA (paliperidone) from Janssen Pharmaceuticals, Inc. The approval updates the drug's lab…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.